**Core Concept**
Hemochromatosis is a genetic disorder characterized by excessive iron absorption, leading to iron overload and tissue damage. The condition can affect multiple organs, including the liver, pancreas, heart, and joints.

**Why the Correct Answer is Right**
Desferrioxamine is a chelating agent that binds to iron and removes it from the body, but it is not the treatment of choice for hemochromatosis. The primary treatment for hemochromatosis involves regular phlebotomy, which involves removing excess iron from the blood through venesection. This approach is more effective and safer than desferrioxamine therapy.

**Why Each Wrong Option is Incorrect**
**Option A:** Hypogonadism is a true statement about hemochromatosis. Excess iron can damage the pituitary gland, leading to hypogonadism, a condition characterized by low sex hormone production.

**Option B:** Ahropathy (osteoarthritis) is also a true statement about hemochromatosis. Iron overload can cause joint damage and lead to osteoarthritis.

**Option C:** Diabetes mellitus is a true statement about hemochromatosis. Iron overload can damage the pancreas, leading to diabetes mellitus.

**Option D:** Desferrioxamine is not the treatment of choice for hemochromatosis, making this statement false.

**Clinical Pearl / High-Yield Fact**
A key clinical feature of hemochromatosis is the presence of a bronze skin pigmentation, known as skin hyperpigmentation. This is due to the deposition of iron in the skin, leading to a characteristic "bronze" appearance.

**✓ Correct Answer:** D. Desferrioxamine is treatment of choice